Showing results (161-170 of 777) with videos related to

Sort By:
Pageof 78
Molecular Cancer Therapeutics|January 14, 2009
Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivoRenate Burger, Steven Le Gouill, Yu-Tzu Tai, et al.
Leukemia|March 1, 2018
Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumorsJooeun Bae, Teru Hideshima, Yu-Tzu Tai, et al.
Biochemical and Biophysical Research Communications|March 17, 2004
TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytesMasaharu Akiyama, Osamu Yamada, Teru Hideshima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2011
In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cellsDharminder Chauhan, Ze Tian, Bin Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2011
Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomideLoredana Santo, Teru Hideshima, Diana Cirstea, et al.
Blood|September 8, 2012
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibitionMichele Cea, Antonia Cagnetta, Mariateresa Fulciniti, et al.
Cancer Discovery|June 18, 2015
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive MyelomaFrancesca Cottini, Teru Hideshima, Rikio Suzuki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Targeting the phosphatidylinositol 3-kinase pathway in multiple myelomaHashem Younes, Xavier Leleu, Evdoxia Hatjiharissi, et al.
British Journal of Haematology|March 25, 2010
Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine modelAjita V Singh, Michael A Palladino, George Kenneth Lloyd, et al.
Blood|April 2, 2011
A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cellsAjita V Singh, Madhavi Bandi, Noopur Raje, et al.
Pageof 78